Nishadil
Signup Signin
Delhi | 25°C (windy)
Cigna's Unsettling Paradox: Stellar Earnings, Yet the Market Balked

Cigna's Unsettling Paradox: Stellar Earnings, Yet the Market Balked
Cigna's Prescription for Change: Saying Goodbye to Drug Rebates

Cigna's Prescription for Change: Saying Goodbye to Drug Rebates
The Great Rebate Rethink: Cigna Steps Up, Promising Relief at the Pharmacy Counter

The Great Rebate Rethink: Cigna Steps Up, Promising Relief at the Pharmacy Counter
Evernorth Charts Ambitious Course with Nasdaq Debut and $1 Billion XRP Treasury Initiative

Evernorth Charts Ambitious Course with Nasdaq Debut and $1 Billion XRP Treasury Initiative
Cigna: Why This Healthcare Powerhouse is Your Next Must-Buy 'SWAN' Bargain!

Cigna: Why This Healthcare Powerhouse is Your Next Must-Buy 'SWAN' Bargain!
Load more..